Single-dose tranexamic acid in advanced ovarian cancer surgery reduces blood loss and transfusions: double-blind placebo-controlled randomized multicenter study. [electronic resource]
Producer: 20140512Description: 335-44 p. digitalISSN:- 1600-0412
- Adult
- Aged
- Aged, 80 and over
- Antifibrinolytic Agents -- administration & dosage
- Blood Loss, Surgical -- prevention & control
- Double-Blind Method
- Drug Administration Schedule
- Erythrocyte Transfusion -- statistics & numerical data
- Female
- Gynecologic Surgical Procedures -- adverse effects
- Hemoglobins -- metabolism
- Humans
- Injections, Intravenous
- Middle Aged
- Neoplasm Staging
- Odds Ratio
- Operative Time
- Ovarian Neoplasms -- blood
- Ovariectomy -- adverse effects
- Preoperative Care -- methods
- Primary Prevention -- methods
- Sweden -- epidemiology
- Tranexamic Acid -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.